Published in J Am Heart Assoc on August 24, 2012
Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms. Hypertension (2013) 1.83
A selective microRNA-based strategy inhibits restenosis while preserving endothelial function. J Clin Invest (2014) 1.52
Calcium release channel RyR2 regulates insulin release and glucose homeostasis. J Clin Invest (2015) 1.38
Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes. Immun Ageing (2013) 1.24
Mitochondrial calcium overload is a key determinant in heart failure. Proc Natl Acad Sci U S A (2015) 1.24
Mitochondrial oxidative stress promotes atrial fibrillation. Sci Rep (2015) 1.09
Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the β adrenergic system. Front Physiol (2013) 1.03
Functional role of Calstabin2 in age-related cardiac alterations. Sci Rep (2014) 0.99
GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility. Cell Commun Signal (2013) 0.95
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor. PLoS One (2013) 0.93
MicroRNAs and Endothelial (Dys) Function. J Cell Physiol (2015) 0.93
Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats. J Diabetes Res (2014) 0.91
microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis. Adv Exp Med Biol (2015) 0.89
The protective effect of microRNA-320 on left ventricular remodeling after myocardial ischemia-reperfusion injury in the rat model. Int J Mol Sci (2014) 0.86
Incidence of branching patterns variations of the arch in aortic dissection in Chinese patients. Medicine (Baltimore) (2015) 0.86
Adrenergic signaling in heart failure and cardiovascular aging. Maturitas (2016) 0.84
Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension. Sci Rep (2015) 0.84
Prevalence and risk factors for resistant hypertension among hypertensive patients from a developing country. BMC Res Notes (2013) 0.83
Recurrent intraventricular thrombus six months after ST-elevation myocardial infarction in a diabetic man: a case report. BMC Res Notes (2013) 0.83
Interactive contribution of serine/threonine kinase 39 gene multiple polymorphisms to hypertension among northeastern Han Chinese. Sci Rep (2014) 0.83
Genetic variations in IL1A and IL1RN are associated with the risk of preeclampsia in Chinese Han population. Sci Rep (2014) 0.83
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy. PLoS One (2015) 0.83
Hemoglobin a1c levels and the risk of cardiovascular disease in people without known diabetes: a population-based cohort study in Japan. Medicine (Baltimore) (2015) 0.82
Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample. BMC Res Notes (2014) 0.82
Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors. BMC Res Notes (2014) 0.82
Association Between Estimated 24-h Urinary Sodium Excretion and Metabolic Syndrome in Korean Adults: The 2009 to 2011 Korea National Health and Nutrition Examination Survey. Medicine (Baltimore) (2016) 0.82
Regulation of CaMKII signaling in cardiovascular disease. Front Pharmacol (2015) 0.82
Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice. Pharmacol Res Perspect (2014) 0.81
Relationship between polymorphisms in beta -2 adrenergic receptor gene and ischemic stroke in North Indian Population: a hospital based case control study. BMC Res Notes (2014) 0.80
Maintenance of normal blood pressure is dependent on IP3R1-mediated regulation of eNOS. Proc Natl Acad Sci U S A (2016) 0.79
"Addressing the impact of stroke risk factors in a case control study in tertiary care hospitals": a case control study in Tertiary Care Hospitals of Peshawar, Khyber Phukhtoonkhwa (KPK) Pakistan. BMC Res Notes (2013) 0.79
Sidestream cigarette smoke and cardiac autonomic regulation. Int Arch Med (2013) 0.79
Comprehensive assessment of the association of WNK4 polymorphisms with hypertension: evidence from a meta-analysis. Sci Rep (2014) 0.79
A novel molecule Me6TREN promotes angiogenesis via enhancing endothelial progenitor cell mobilization and recruitment. Sci Rep (2014) 0.79
Microalbuminuria and left ventricular hypertrophy among newly diagnosed black African hypertensive patients: a cross sectional study from a tertiary hospital in Uganda. BMC Res Notes (2015) 0.79
Sox17 is required for normal pulmonary vascular morphogenesis. Dev Biol (2014) 0.78
Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt/β-catenin signaling pathway. Ther Clin Risk Manag (2015) 0.78
Novel Association Between the Reverse-Dipper Pattern of Ambulatory Blood Pressure Monitoring and Metabolic Syndrome in Men But Not in Women. Medicine (Baltimore) (2015) 0.78
Association Between Vascular Access Dysfunction and Subsequent Major Adverse Cardiovascular Events in Patients on Hemodialysis: A Population-Based Nested Case-Control Study. Medicine (Baltimore) (2015) 0.77
Giant left atrial myxoma mimicking severe mitral valve stenosis and severe pulmonary hypertension. Int Arch Med (2013) 0.77
New small molecules, ISA27 and SM13, inhibit tumour growth inducing mitochondrial effects of p53. Br J Cancer (2014) 0.77
Anesthetic challenges of patients with cardiac comorbidities undergoing major urologic surgery. Int Arch Med (2014) 0.77
Phenanthrene exposure induces cardiac hypertrophy via reducing miR-133a expression by DNA methylation. Sci Rep (2016) 0.77
Association between obesity and high blood pressure among Lithuanian adolescents: a cross-sectional study. Ital J Pediatr (2014) 0.77
The association of leptin with dyslipidemia, arterial hypertension and obesity in Kyrgyz (Central Asian nation) population. BMC Res Notes (2014) 0.77
Addressing the relationship between cardiac hypertrophy and ischaemic stroke: an observational study. Int Arch Med (2012) 0.76
Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage. BMC Res Notes (2014) 0.76
Association of Genetic Polymorphisms on VEGFA and VEGFR2 With Risk of Coronary Heart Disease. Medicine (Baltimore) (2016) 0.76
Fish, Long-Chain n-3 PUFA and Incidence of Elevated Blood Pressure: A Meta-Analysis of Prospective Cohort Studies. Nutrients (2016) 0.76
Relationship between red cell distribution width and serum uric acid in patients with untreated essential hypertension. Sci Rep (2014) 0.76
Estimated Glomerular Filtration Rate and Systolic Time Intervals in Risk Stratification for Increased Left Ventricular Mass Index and Left Ventricular Hypertrophy. Medicine (Baltimore) (2016) 0.76
Serum lipocalin-2 levels are positively associated with not only total body fat but also visceral fat area in Chinese men. Medicine (Baltimore) (2016) 0.75
Association between circulating levels of ACE2-Ang-(1-7)-MAS axis and ACE2 gene polymorphisms in hypertensive patients. Medicine (Baltimore) (2016) 0.75
Sudden cardiac death diagnosed with dilated cardiomyopathy in a Kuwaiti family: a case report. BMC Res Notes (2014) 0.75
Cardiac Rehabilitation in Real Life. Medicine (Baltimore) (2015) 0.75
Prognostic Value of Plasma Intermedin Level in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. Medicine (Baltimore) (2016) 0.75
Graves' disease presenting as bi-ventricular heart failure with severe pulmonary hypertension and pre-eclampsia in pregnancy--a case report and review of the literature. BMC Res Notes (2014) 0.75
Inverse Association of Serum Docosahexaenoic Acid With Newly Diagnosed Hypertension: A Community-based Case-control Study. Medicine (Baltimore) (2016) 0.75
Functional Inducible Nitric Oxide Synthase Gene Variants Associate With Hypertension: A Case-Control Study in a Finnish Population-The TAMRISK Study. Medicine (Baltimore) (2015) 0.75
Genetic Association Studies Reporting on Variants in the C-Reactive Protein Gene and Coronary Artery Disease: A Meta-Analysis. Medicine (Baltimore) (2015) 0.75
Cardiovascular responses induced by Catalase Inhibitior into the Fourth Cerebral Ventricle is changed in Wistar rats exposed to sidestream cigarette smoke. Int J Health Sci (Qassim) (2013) 0.75
Increased mean aliphatic lipid chain length in left ventricular hypertrophy secondary to arterial hypertension: A cross-sectional study. Medicine (Baltimore) (2016) 0.75
Aspiration Thrombectomy and Drug-Eluting Stent Implantation Decrease the Occurrence of Angina Pectoris One Year After Acute Myocardial Infarction. Medicine (Baltimore) (2016) 0.75
Comparative clinical implications of admission electrocardiographic findings for patients with non-ST-segment elevation myocardial infarction. Medicine (Baltimore) (2016) 0.75
A propensity score-matching analysis of transthoracic echocardiography and abdominal ultrasonography for the detection of abdominal aortic aneurysms. Clin Med Insights Cardiol (2015) 0.75
The Prognostic Role of Angiotensin II Type 1 Receptor Autoantibody in Non-Gravid Hypertension and Pre-eclampsia: A Meta-analysis and Our Studies. Medicine (Baltimore) (2016) 0.75
Digital ankle-brachial index technology used in primary care settings to detect flow obstruction: a population based registry study. BMC Res Notes (2013) 0.75
Endothelin Type A Receptor Genotype is a Determinant of Quantitative Traits of Metabolic Syndrome in Asian Hypertensive Families: A SAPPHIRe Study. Front Endocrinol (Lausanne) (2013) 0.75
Prehypertension in adolescents with cardiovascular risk: a comparison between type 1 diabetic patients and overweight subjects. BMC Res Notes (2016) 0.75
Elevated plasma migration inhibitory factor in hypertension-hyperlipidemia patients correlates with impaired endothelial function. Medicine (Baltimore) (2016) 0.75
Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors. Medicine (Baltimore) (2015) 0.75
Models for preclinical studies in aging-related disorders: One is not for all. Transl Med UniSa (2016) 0.75
Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy. Sci Rep (2016) 0.75
Effect of multiple clinical factors on recurrent angina after percutaneous coronary intervention: A retrospective study from 398 ST-segment elevation myocardial infarction patients. Medicine (Baltimore) (2016) 0.75
Effects of liraglutide on hemodynamic parameters in patients with heart failure. Oncotarget (2017) 0.75
Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (1995) 9.86
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest (2000) 3.70
Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res (2001) 3.18
Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet (2007) 3.04
Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol Cell Biol (1994) 2.52
Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension (1998) 2.31
Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res (2004) 2.00
Impaired synaptic plasticity and cAMP response element-binding protein activation in Ca2+/calmodulin-dependent protein kinase type IV/Gr-deficient mice. J Neurosci (2000) 1.81
Calcium calmodulin-dependent protein kinase IV is required for fear memory. Nat Neurosci (2002) 1.70
Reactive oxygen species-activated Ca/calmodulin kinase IIδ is required for late I(Na) augmentation leading to cellular Na and Ca overload. Circ Res (2011) 1.69
Role of CaMKIIdelta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure. Proc Natl Acad Sci U S A (2010) 1.63
Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo. Hypertension (2012) 1.62
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res (2005) 1.57
Coronary heart disease risk factors and mortality. JAMA (2012) 1.56
Cerebellar defects in Ca2+/calmodulin kinase IV-deficient mice. J Neurosci (2000) 1.55
Regulation of myocardial betaARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing alpha1B-adrenergic receptors. J Am Coll Cardiol (2001) 1.53
Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ. Mol Cell (2011) 1.52
Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. Hypertension (2010) 1.47
Pressure overload selectively up-regulates Ca2+/calmodulin-dependent protein kinase II in vivo. Mol Endocrinol (2003) 1.40
The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. J Hypertens (2007) 1.35
Analysis of CaM-kinase signaling in cells. Cell Calcium (2011) 1.30
In vivo properties of the proangiogenic peptide QK. J Transl Med (2009) 1.26
Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Circ Res (2008) 1.26
Real-time two-dimensional Doppler echocardiographic flow mapping. Circulation (1985) 1.25
Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. Br J Pharmacol (2007) 1.22
G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. Am J Cardiol (2011) 1.19
Association study on long-living individuals from Southern Italy identifies rs10491334 in the CAMKIV gene that regulates survival proteins. Rejuvenation Res (2011) 1.17
AKT participates in endothelial dysfunction in hypertension. Circulation (2004) 1.15
Age-related impairment in insulin release: the essential role of β(2)-adrenergic receptor. Diabetes (2012) 1.15
Regional alterations of repolarizing K+ currents among the left ventricular free wall of rats with ascending aortic stenosis. J Physiol (2001) 1.13
Position of the American Heart Association on research animal use. Circulation (1985) 1.12
Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis. Cell Signal (2011) 1.10
CaMKII and CaMKIV mediate distinct prosurvival signaling pathways in response to depolarization in neurons. Mol Cell Neurosci (2007) 1.09
Purification and characterization of a brain-specific multifunctional calmodulin-dependent protein kinase from rat cerebellum. J Biol Chem (1992) 1.06
Involvement of Ca2+/calmodulin-dependent protein kinase II in endothelial NO production and endothelium-dependent relaxation. Am J Physiol Heart Circ Physiol (2003) 1.04
Reduction in basal nitric oxide activity causes albuminuria. Diabetes (2011) 1.01
Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit. J Transl Med (2011) 0.99
Mechanoelectrical remodeling and arrhythmias during progression of hypertrophy. FASEB J (2009) 0.95
Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. Eur J Heart Fail (2011) 0.92
Myocardial G protein-coupled receptor kinases: implications for heart failure therapy. Proc Assoc Am Physicians (1999) 0.91
Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats. J Hepatol (1997) 0.91
Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis. Angiogenesis (2008) 0.89
Insulin enhances endothelial alpha2-adrenergic vasorelaxation by a pertussis toxin mechanism. Hypertension (1997) 0.88
Effects of heart disease on cardiac ion current density versus current amplitude: important conceptual subtleties in the language of arrhythmogenic ion channel remodeling. Circ Res (2008) 0.88
PLC/CAMK IV-NF-kappaB involved in the receptor for advanced glycation end products mediated signaling pathway in human endothelial cells. Mol Cell Endocrinol (2010) 0.86
Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology (2012) 0.83
MicroRNA-133 controls cardiac hypertrophy. Nat Med (2007) 11.68
Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell (2013) 4.99
Retracted Genetic signatures of exceptional longevity in humans. Science (2010) 4.33
Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis. J Am Coll Cardiol (2013) 3.61
ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med (2002) 3.36
Genetic signatures of exceptional longevity in humans. PLoS One (2012) 3.20
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A (2002) 3.18
Life-long sustained mortality advantage of siblings of centenarians. Proc Natl Acad Sci U S A (2002) 2.96
MicroRNAs and cardiac pathology. Nat Rev Cardiol (2009) 2.50
Emerging role of microRNAs in cardiovascular biology. Circ Res (2007) 2.41
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res (2009) 2.40
Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J (2005) 2.29
Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res (2009) 2.24
Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals. Am J Cardiol (2005) 2.14
G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. High Blood Press Cardiovasc Prev (2013) 2.13
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease. JACC Cardiovasc Interv (2013) 2.11
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res (2004) 2.08
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest (2010) 2.04
Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension (2012) 2.02
Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation (2011) 1.99
Initial left-ventricular mass predicts probability of uncontrolled blood pressure in arterial hypertension. J Hypertens (2011) 1.97
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation (2009) 1.92
IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. Proc Natl Acad Sci U S A (2011) 1.87
MicroRNAs: components of an integrated system controlling cardiac development, physiology, and disease pathogenesis. Cardiovasc Res (2008) 1.75
MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol (2010) 1.74
Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives. Am J Hypertens (2002) 1.74
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res (2013) 1.72
MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res (2011) 1.67
Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes (2002) 1.65
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. J Am Coll Cardiol (2008) 1.65
MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro. J Cell Biol (2010) 1.64
Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo. Hypertension (2012) 1.62
Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am Heart J (2006) 1.59
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res (2005) 1.57
Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation (2012) 1.56
Increased basal nitric oxide release despite enhanced free radical production in hypertension. J Hypertens (2002) 1.54
MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/-mice. Thromb Haemost (2014) 1.53
Insulin stimulates fibroblast proliferation through calcium-calmodulin-dependent kinase II. Cell Cycle (2009) 1.53
Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ. Mol Cell (2011) 1.52
Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine. Kidney Int (2005) 1.52
Cardiovascular health in migrants: current status and issues for prevention. A collaborative multidisciplinary task force report. J Cardiovasc Med (Hagerstown) (2014) 1.50
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. J Cell Physiol (2008) 1.48
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway. Cardiovasc Res (2012) 1.48
Cardiovascular risk in relation to a new classification of hypertensive left ventricular geometric abnormalities. J Hypertens (2015) 1.47
Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. Hypertension (2010) 1.47
Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J Biol Chem (2003) 1.47
Hypertensive target organ damage predicts incident diabetes mellitus. Eur Heart J (2013) 1.47
Angiotensin II receptor blockers and myocardial infarction: deeds and misdeeds. J Hypertens (2005) 1.47
The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells: another piece in the adipokines puzzle. Thromb Res (2012) 1.45
An exaggerated systolic blood pressure response to exercise is associated with cardiovascular remodeling in subjects with prehypertension. Ital Heart J (2005) 1.45
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. Proc Natl Acad Sci U S A (2008) 1.44
Mortality reduction with transradial approach in patients with ST-segment elevation myocardial infarction: is the randomized evidence conclusive? Int J Cardiol (2013) 1.43
TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives. J Hypertens (2015) 1.43
Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey. J Hypertens (2002) 1.41
Blood pressure control according to new guidelines targets in low- to high-risk hypertensives managed in specialist practice. J Hypertens (2004) 1.41
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2011) 1.40
Microalbuminuria predicts the recurrence of cardiovascular events in patients with essential hypertension. J Hypertens (2016) 1.40
Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial. High Blood Press Cardiovasc Prev (2015) 1.40
[Hypertensive heart disease: diagnostic and therapeutic guidelines]. G Ital Cardiol (Rome) (2008) 1.39
Calcium release channel RyR2 regulates insulin release and glucose homeostasis. J Clin Invest (2015) 1.38
Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide. Proc Natl Acad Sci U S A (2005) 1.38
Physiological myocardial hypertrophy: how and why? Front Biosci (2008) 1.35
The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. J Hypertens (2007) 1.35
MicroRNA and cardiac pathologies. Physiol Genomics (2008) 1.32
Retraction. Science (2011) 1.32
New susceptibility locus for hypertension on chromosome 8q by efficient pedigree-breaking in an Italian isolate. Hum Mol Genet (2006) 1.29
Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy. Circ Res (2009) 1.29
Calmodulin-dependent protein kinase IV regulates hematopoietic stem cell maintenance. J Biol Chem (2005) 1.28
Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability. J Cell Biol (2009) 1.28
Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J (2004) 1.27
In vivo properties of the proangiogenic peptide QK. J Transl Med (2009) 1.26
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. Cardiovasc Res (2008) 1.26
Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes. Immun Ageing (2013) 1.24
G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. Circulation (2011) 1.23
Circulating microRNAs and aerobic fitness--the HUNT-Study. PLoS One (2013) 1.20
MicroRNAs in cardiovascular biology and heart disease. Circ Cardiovasc Genet (2009) 1.19
Regulation of cell size and contractile function by AKT in cardiomyocytes. Ann N Y Acad Sci (2004) 1.19
G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. Am J Cardiol (2011) 1.19
Association study on long-living individuals from Southern Italy identifies rs10491334 in the CAMKIV gene that regulates survival proteins. Rejuvenation Res (2011) 1.17